TipRanks on MSN

HeartBeam (NASDAQ: BEAT) secures FDA 510(k) clearance for 12-lead ECG synthesis software following successful appeal

Austin, Texas, United States, December 10th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused ...
Becker's Hospital Review

U of Michigan AI detects heart disease from EKG

Researchers at Ann Arbor, Mich.-based University of Michigan have developed an AI model that can detect coronary microvascular dysfunction — a frequently missed and difficult-to-diagnose heart ...
Fierce Biotech

HeartBeam swells on turning FDA rejection into ECG clearance

After receiving word late last month that the FDA would not be issuing a 510(k) clearance to its cable-free electrocardiogram ...
InvestorsHub on MSN

HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software

HeartBeam Inc. (NASDAQ:BEAT) saw its stock soar 52.6% in premarket trading Wednesday after the company announced that the FDA ...